glp 1 drugs depression UF researchers demonstrate GLP-1RAs' potential to treat Wegovy leads to weight loss.

Though findings have been promising, there is a need for gold-standard randomized controlled trials to inform clinical decision making and practice

These data suggest that d-allulose may moderately enhance energy expenditure, which might additionally contribute to attenuation of visceral obesity, in agreement with previous reports that d-allulose increases energy expenditure 29

However, this doesnt capture probiotics added to foods and beverages, a growing opportunity, added Dickerson

Key hormones released by EECs include GLP-1, GIP, cholecystokinin (CCK), ghrelin, and peptide YY (PYY)

December 2025: Johnson & Johnson (pharmaceutical segment collaborations) progressed metabolic disease R&D programs focusing on novel combination therapies for diabetes management

high-dose opioids) can lead to delayed gastric emptying and concern for aspiration